Freeze-Dried Platelet Product for the Treatment of Trauma-Associated Blood Loss in Canines
DEPT OF DEFENSE
Who can apply
No Set aside used. NONE
About this opportunity
The OPMED is conducting market research to identify technologies that meet requirements for the development of a freeze-dried platelet product for the treatment of trauma-associated blood loss in canines. This market research may also assist with the further development and/or refinement of the requirements. Military Working Dogs (MWDs) play a critical role in protecting human lives and supporting military objectives in the operational environment. MWDs work in close conjunction with their handlers and Service Members and are exposed to the same combat trauma threats and similar non-battle injury risks, and thus canine blood or blood components are indicated for appropriate treatment. The OPMED has a requirement to develop, deliver, and field safe and effective Canine Blood Products (CBP) ...